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Oesophageal cancer is the eighth most common cancer in the
world, with striking geographical variations in incidence (Parkin,
2001). It accounts for approximately 1 in 40 of all cancers among
adults in England and Wales, with an average of some 6000 new cases
a year, of which some 60% occur in men (Quinn et al, 2001).
Incidence has increased steadily in both sexes since the 1970s.
Lifetime risks up to the age of 74 years are currently approximately
1% in men and 0.4% in women (Parkin et al,2 0 0 2 ) .T r e n d si n
mortality are similar to those for incidence, because survival has been
poor for many years. The incidence of adenocarcinoma of the lower
third of the oesophagus and the gastric cardia has been increasing for
20 years in England (Powell and McConkey, 1990; Newnham et al,
2003) and in other countries (Bollschweiler et al,2 0 0 1 ) .M o r et h a n
90% of squamous cell carcinomas can be attributed to alcohol and
tobacco in Europe and North America, whereas the main risk factor
for adenocarcinoma is Barrett’s oesophagus. Oesophageal cancer has
an extremely poor prognosis: the average 5-year relative survival rate
among adults diagnosed in 22 European countries during the early
1990s was approximately 10% (Sant et al, 2003).
We analysed data for 65591 patients diagnosed with oesopha-
geal cancer in England and Wales during the period 1986–1999,
approximately 84% of those eligible, with follow-up to the end of
2001. Exclusions from analysis were mainly of patients whose
recorded survival was zero (10.8%) or whose cancer of the
oesophagus was not their first primary malignancy (3.6%). A third
(34%) of tumours were squamous carcinomas, but the proportion
classified as adenocarcinoma rose from 32 to 44% during the 1990s,
continuing a steady increase from 15% in the early 1970s (Coleman
et al, 1999). Annual incidence rates increased by about one-third in
men and women during the period 1986–1999. Trends were similar
for all deprivation groups in both sexes, and incidence was lowest in
the most affluent groups throughout (Figure 1).
SURVIVAL TRENDS
Relative survival at 1 year increased significantly from the late
1980s to the late 1990s in both sexes, from 23.8 to 29.6% in men
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Figure 1 Trends in the age-standardised incidence of oesophageal
cancer in adults aged 15–99 years, by sex and deprivation group: England
and Wales, 1986–1999.
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and from 24.4 to 26.8% in women (þ1.4% every 5 years) (Table 1,
Figure 2). Five-year survival increased from 6.3 to 7.6% in men
over the same period (average increase þ1.7% every 5 years), but
there was no change in 5-year survival for women: 7.4% for those
diagnosed during 1986–1990 and 7.2% for those diagnosed during
1996–1999. Short-term predictions of survival for patients
diagnosed during 2000–2001, using hybrid analysis (Brenner and
Rachet, 2004), suggest a small continuing increase in survival at 1,
5 and 10 years after diagnosis (Table 1).
Table 1 Trends in relative survival (%) by sex, time since diagnosis and calendar period of diagnosis: England and Wales, adults (15–99 years) diagnosed
during 1986–1999 and followed up to 2001
Calendar period of diagnosis
a
Average change (%) Prediction
c for patients
1986–1990 1991–1995 1996–1999 every 5 years
b diagnosed during 2000–2001
Time since
diagnosis
Survival
(%) 95% CI
Survival
(%) 95% CI
Survival
(%) 95% CI
Survival
(%) 95% CI
Survival
(%) 95% CI
1 year Men 23.8 (23.1, 24.6) 26.7 (26.0, 27.5) 29.6 (28.7, 30.4) 3.7** (2.1, 5.3) 30.6 (29.4, 31.7)
Women 24.4 (23.4, 25.4) 25.9 (25.0, 26.8) 26.8 (25.8, 27.8) 1.3 ( 0.6, 3.3) 27.2 (25.8, 28.6)
5 years Men 6.3 (5.9, 6.9) 6.3 (5.8, 6.7) 7.6 (7.0, 8.2) 1.7** (0.6, 2.8) 8.0 (7.2, 8.7)
Women 7.4 (6.8, 8.1) 7.4 (6.9, 8.0) 7.2 (6.5, 8.0)  0.3 ( 1.7, 1.0) 7.8 (6.9, 8.8)
10 years Men 5.1 (4.6, 5.6) 4.8 (4.3, 5.2) 2.0* (0.2, 3.7) 6.5 (5.7, 7.3)
Women 6.2 (5.6, 6.8) 6.3 (5.7, 6.9) 0.7 ( 1.7, 3.1) 6.5 (5.6, 7.5)
CI¼confidence interval.
aSurvival estimated with cohort or complete approach (see Rachet et al, 2008).
bMean absolute change (%) in survival every 5 years, adjusted for
deprivation (see Rachet et al, 2008).
cSurvival estimated with hybrid approach (see Rachet et al, 2008). *Po0.05; **Po0.01.
0
20
40
60
80
100
R
e
l
a
t
i
v
e
 
s
u
r
v
i
v
a
l
 
(
%
)
0 2 4 6 8 10
Years since diagnosis
2000–2001
1996–1999
1991–1995
1986–1990
Women
0
40
20
60
80
100
R
e
l
a
t
i
v
e
 
s
u
r
v
i
v
a
l
 
(
%
)
0 2 4 6 8 10
Years since diagnosis
Men
Figure 2 Relative survival (%) up to 10 years after diagnosis by sex and calendar period of diagnosis: England and Wales, adults (15–99 years) diagnosed
during 1986–1999 and followed up to 2001. Survival estimated with cohort or complete approach (1986–1990, 1991–1995, 1996–1999) or hybrid
approach (2000–2001) (see Rachet et al, 2008).
Table 2 Trends in the deprivation gap in relative survival (%) by sex, time since diagnosis and calendar period of diagnosis: England and Wales, adults
(15–99 years) diagnosed during 1986–1999 and followed up to 2001
Calendar period of diagnosis
a
Average change (%) Prediction
c for patients
1986–1990 1991–1995 1996–1999 every 5 years
b diagnosed during 2000–2001
Time since
diagnosis
Deprivation
gap (%) 95% CI
Deprivation
gap (%) 95% CI
Deprivation
gap (%) 95% CI
Deprivation
gap (%) 95% CI
Deprivation
gap (%) 95% CI
1 year Men  3.3** ( 5.6,  1.0)  5.2** ( 7.3,  3.0)  4.8** ( 7.2,  2.4)  0.8 ( 2.6, 0.9)  5.0** ( 8.4,  1.6)
Women  2.0 ( 4.8, 0.9)  4.1** ( 6.8,  1.4)  2.1 ( 5.0, 0.9)  0.1 ( 2.3, 2.0)  3.9 ( 8.0, 0.2)
5 years Men 0.7 ( 0.7, 2.1)  0.8 ( 2.0, 0.5)  1.9* ( 3.8,  0.1)  1.4* ( 2.6,  0.1)  2.6* ( 4.8,  0.4)
Women  0.9 ( 2.8, 1.0)  1.8* ( 3.5,  0.1)  0.2 ( 2.4, 2.0) 0.3 ( 1.2, 1.8)  0.3 ( 2.9, 2.3)
10 years Men 1.5* (0.1, 2.9)  1.2 ( 2.5, 0.2)  2.7** ( 4.6,  0.7)  2.3* ( 4.6, 0.0)
Women  0.2 ( 2.1, 1.7)  1.0 ( 2.8, 0.9)  0.7 ( 3.4, 1.9) 0.1 ( 2.5, 2.7)
CI¼confidence interval.
aSurvival estimated with cohort or complete approach (see Rachet et al, 2008).
bMean absolute change (%) in the deprivation gap in survival every
5 years, adjusted for the underlying trend in survival (see Rachet et al, 2008).
cSurvival estimated with hybrid approach (see Rachet et al, 2008). *Po0.05; **Po0.01.
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The deprivation gap was more marked in men (Table 2, Figure 3). For
1-year survival, the deprivation gap remained unchanged at approxi-
mately  5% (lower for the most deprived group than for the most
affluent), but for survival at 5 and 10 years, the deprivation gap
widened significantly every 5 years by  1.4% for 5-year survival and by
 2.7% for 10-year survival. For women, the deprivation gap in survival
was less marked, and did not change significantly over time.
COMMENT
Survival from oesophageal cancer in England and Wales remains
very poor, with 5-year relative survival approximately 7.5%, and
no major improvement for patients diagnosed between 1986 and
1999. Five-year survival was already 6–7% for patients diagnosed
in 1971–1975 (Coleman et al, 1999). This suggests a lack of
substantial progress in diagnostic or therapeutic management over
the last 30 years. However, the slight improvement in 1-year
survival for both sexes suggests a decrease in postoperative
mortality (Faivre et al, 1998). There was a trend towards higher
5-year survival for men, accompanied by a significant increase in
the deprivation gap; this was not seen for women. As stage at
diagnosis is the main prognostic factor for oesophageal cancer,
and incidence trends were similar in all deprivation groups, these
trends in 5-year survival may suggest a trend towards earlier stage
at diagnosis for men in the more affluent groups, with a higher
proportion being referred for potentially curative resection.
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Figure 3 Trends in the deprivation gap in 5-year relative survival (%) by sex and calendar period of diagnosis: England and Wales, adults (15–99 years)
diagnosed during 1986–1999 and followed up to 2001.
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